BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, March 9, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

April 17, 2002

View Archived Issues

The role of statins in the treatment of multiple sclerosis

Read More

Alizyme reviews 2001, profiles future expectations

Read More

Lilly and Ligand extend collaboration in type 2 diabetes, cardiovascular disorders and obesity

Read More

BioMarin and Genzyme initiate rolling BLA for Aldurazyme

Read More

Positive phase I/IIa data reported for NCX-4016 in symptomatic peripheral arterial disease

Read More

Adolor's alvimopan will be codeveloped with GSK

Read More

Oral PTH analogue for osteoporosis licensed to GlaxoSmithKline

Read More

Late-breaking AACR presentation describes preclinical profile of new orally active mTOR inhibitor

Read More

FDA grants priority review to Arimidex in early breast cancer

Read More

Abgenix and Diabetogen enter antibody therapy collaboration for autoimmune disease

Read More

Go-ahead received for group A Streptococcus vaccine trial

Read More

Glivec approved in Switzerland for GISTs

Read More

Phase III U.S. trials start for hepatitis C combination therapy in nonresponders

Read More

Arcoxia granted major approval for relief of arthritis and pain

Read More

Novel VTA from Oxigene markedly reduces tumor blood flow and exerts potent antitumor effects

Read More

Semisynthetic andrographolide analogue with immunomodulating and antitumor activity

Read More

AACR presentations provide further preclinical characterization of epothilone D

Read More

AVI-4126 may be useful alone or in combination in the treatment of prostate cancer

Read More

Vanilloid receptor antagonists possessing analgesic and antiinflammatory properties

Read More

Novel factor Xa inhibitors identified at Morphochem

Read More

Boehringer Ingelheim claims new series of sodium channel blockers

Read More

Estrogen receptor modulators and their use described by Akzo Nobel team

Read More

Dipeptide inhibitors of apoptosis in development at Cytovia

Read More

Integrin inhibitors with a biphenyl structure designed at Merck

Read More

New delivery agents reported in recent patent by Emisphere

Read More

PNU-183792 found to be active in an animal model of lethal MCMV infection

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 9, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 3, 2026
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent

    BioWorld Science
    Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing